{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:45:57Z","timestamp":1767141957549,"version":"build-2238731810"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11886-021-01466-7","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T08:28:22Z","timestamp":1615278502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Transcatheter Mitral Valve Implantation Systematic Review: Focus on Transseptal Approach and Mitral Annulus Calcification"],"prefix":"10.1007","volume":"23","author":[{"given":"W.","family":"Ben-Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rod\u00e8s-Cabeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. S.","family":"von Bardeleben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mylotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Granada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Modine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"key":"1466_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/heartjnl-2014-307020","volume":"102","author":"S Coffey","year":"2016","unstructured":"Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease. Heart. 2016;102:75\u201385.","journal-title":"Heart"},{"key":"1466_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","volume":"368","author":"VT Nkomo","year":"2006","unstructured":"Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population- based study. Lancet. 2006;368:1005\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(06)69208-8.","journal-title":"Lancet"},{"key":"1466_CR3","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/eurheartj\/ehm001","volume":"28","author":"M Mirabel","year":"2007","unstructured":"Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358\u201365. https:\/\/doi.org\/10.1093\/eurheartj\/ehm001.","journal-title":"Eur Heart J."},{"key":"1466_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jacc.2013.08.723","volume":"63","author":"SS Goel","year":"2014","unstructured":"Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol. 2014;63:185\u20136.","journal-title":"J Am Coll Cardiol."},{"key":"1466_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1136\/heartjnl-2017-311412","volume":"104","author":"M Chiarito","year":"2018","unstructured":"\u2022\u2022 Chiarito M, Pagnesi M, Martino EA, Pighi M, Scotti A, Biondi-Zoccai G, et al. Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis. Heart. 2018;104:306\u201312. A significant proportion of patients are considered to be suboptimal candidates for transcatheter mitral valve repair. Residual moderate or severe MR rates of up to 10% have been reported in this large meta-analysis of real-world patients undergoing transcatheter mitral valve repair. https:\/\/doi.org\/10.1136\/heartjnl-2017-311412.","journal-title":"Heart"},{"key":"1466_CR6","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/eurheartj\/ehv123","volume":"36","author":"F Maisano","year":"2015","unstructured":"Maisano F, Alfieri O, Banai S, et al. The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? Eur Heart J. 2015;36:1651\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehv123.","journal-title":"Eur Heart J."},{"key":"1466_CR7","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1056\/NEJM196211012671802","volume":"267","author":"D Korn","year":"1962","unstructured":"Korn D, Desanctis RW, Sell S. Massive calcification of the mitral annulus. A clinicopathological study of fourteen cases. N Engl J Med. 1962;267:900\u20139. https:\/\/doi.org\/10.1056\/NEJM196211012671802.","journal-title":"N Engl J Med."},{"key":"1466_CR8","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/0002-8703(46)90004-X","volume":"31","author":"MH Fertman","year":"1946","unstructured":"Fertman MH, Wolff L. Calcification of the mitral valve. Am Heart J. 1946;31:580\u20139. https:\/\/doi.org\/10.1016\/0002-8703(46)90004-X.","journal-title":"Am Heart J."},{"key":"1466_CR9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s11748-013-0207-7","volume":"61","author":"Y Okada","year":"2013","unstructured":"Okada Y. Surgical management of mitral annular calcification. Gen Thorac Cardiovasc Surg. 2013;61:619\u201325. https:\/\/doi.org\/10.1007\/s11748-013-0207-7.","journal-title":"Gen Thorac Cardiovasc Surg."},{"issue":"1","key":"1466_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S1010-7940(99)00358-9","volume":"17","author":"M Genoni","year":"2000","unstructured":"Genoni M, Franzen D, Vogt P, Seifert B, Jenni R, Kunzli A, et al. Paravalvular leakage after mitral valve replace- ment: improved long-term survival with aggressive surgery? Eur J Cardiothorac Surg. 2000;17(1):14\u20139.","journal-title":"Eur J Cardiothorac Surg."},{"issue":"4","key":"1466_CR11","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.ejcts.2008.06.009","volume":"34","author":"H Deniz","year":"2008","unstructured":"Deniz H, Sokullu O, Sanioglu S, Sargin M, Ozay B, Ayoglu U, et al. Risk factors for posterior ventricular rupture after mitral valve replacement: results of 2560 patients. Eur J Cardiothorac Surg. 2008;34(4):780\u20134.","journal-title":"Eur J Cardiothorac Surg."},{"issue":"13","key":"1466_CR12","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jcin.2016.04.022","volume":"9","author":"M Guerrero","year":"2016","unstructured":"Guerrero M, Dvir D, Himbert D, Urena M, Eleid M, Wang DD, et al. Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first multicenter global registry. JACC Cardiovasc Interv.63. 2016;9(13):1361\u201371.","journal-title":"JACC Cardiovasc Interv.63."},{"key":"1466_CR13","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"D Stroup","year":"2000","unstructured":"Stroup D, Berlin J, Morton S, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. JAMA. 2000;283:2008\u201312.","journal-title":"JAMA"},{"key":"1466_CR14","first-page":"349","volume":"g7647","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;g7647:349.","journal-title":"BMJ"},{"issue":"7","key":"1466_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11936-019-0734-3","volume":"21","author":"SC El Hajj","year":"2019","unstructured":"El Hajj SC, Eleid MF. Transcatheter mitral valve replacement: an update on the current literature. Curr Treat Options Cardiovasc Med. 2019;21(7):35.","journal-title":"Curr Treat Options Cardiovasc Med."},{"key":"1466_CR16","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27:1785\u2013805. https:\/\/doi.org\/10.1177\/0962280216669183.","journal-title":"Stat Methods Med Res."},{"key":"1466_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J. TongT. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"key":"1466_CR18","first-page":"355","volume":"i4919","author":"JAC Sterne","year":"2016","unstructured":"Sterne JAC, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. BMJ. 2016;i4919:355.","journal-title":"BMJ"},{"issue":"11","key":"1466_CR19","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jacc.2018.12.066","volume":"73","author":"P Sorajja","year":"2019","unstructured":"Sorajja P, Moat N, Badhwar V, et al. Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients. J Am Coll Cardiol. 2019;73(11):1250\u201360.","journal-title":"J Am Coll Cardiol."},{"key":"1466_CR20","unstructured":"Cheung A. Latest updates from the world of TMVR: transapical Neovasc. Paper presented at: PCR London Valves. London, United Kingdom: 2019."},{"issue":"1","key":"1466_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jacc.2017.10.061","volume":"71","author":"V Bapat","year":"2018","unstructured":"Bapat V, Rajagopal V, Meduri C, et al. Early experience with new transcatheter mitral valve replacement. J Am Coll Cardiol. 2018;71(1):12\u201321.","journal-title":"J Am Coll Cardiol."},{"key":"1466_CR22","unstructured":"Piazza N. The HIGHLIFE Program: Attributes, Challenges, and Clinical Data. Paper presented at: The Structural Heart Disease Summit (SHDS). Chicago, IL: 2018."},{"key":"1466_CR23","unstructured":"Piazza N. Transcatheter mitral valve replacement: HighLife. Paper presented at: Transcatheter cardiovascular therapeutics (TCT). Denver, CO: 2017."},{"key":"1466_CR24","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.jcin.2017.05.032","volume":"10","author":"A Regueiro","year":"2017","unstructured":"Regueiro A, Ye J, Fam N, Bapat VN, Dagenais F, Peterson MD, et al. 2-Year outcomes after transcatheter mitral valve replacement. JACC Cardiovasc Intervent. 2017;10:1671\u20138. https:\/\/doi.org\/10.1016\/j.jcin.2017.05.032.","journal-title":"JACC Cardiovasc Intervent."},{"key":"1466_CR25","doi-asserted-by":"publisher","unstructured":"Webb J. Latest updates from the world of TMVR: transseptal SAPIEN M3 TMVR. Paper presented at: PCR London Valves. London, United Kingdom: 2019, DOI: https:\/\/doi.org\/10.3389\/fnint.2019.00071.","DOI":"10.3389\/fnint.2019.00071"},{"key":"1466_CR26","volume-title":"Latest updates from the world of TMVR: Caisson TMVR. Paper presented at: PCR London Valves","author":"M Williams","year":"2019","unstructured":"Williams M. Latest updates from the world of TMVR: Caisson TMVR. Paper presented at: PCR London Valves. London: United Kingdom; 2019."},{"key":"1466_CR27","doi-asserted-by":"publisher","unstructured":"Asgar AW. Percutaneous Mitral Valve Replacement Technology Update. Paper presented at: Transcatheter cardiovascular therapeutics (TCT). San Francisco, CA: 2019, DOI: https:\/\/doi.org\/10.1016\/j.jcin.2020.11.022.","DOI":"10.1016\/j.jcin.2020.11.022"},{"key":"1466_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fnint.2019.00071","volume-title":"United Kingdom","author":"J Webb","year":"2019","unstructured":"Webb J. Latest updates from the world of TMVR: transseptal Evoque TMVR. Paper presented at: PCR London Valves. London. In: United Kingdom; 2019. https:\/\/doi.org\/10.3389\/fnint.2019.00071."},{"key":"1466_CR29","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV15I7A103","volume-title":"Latest updates from the world of TMVR: Cephea TMVR. Paper presented at: PCR London Valves","author":"T Modine","year":"2019","unstructured":"Modine T. Latest updates from the world of TMVR: Cephea TMVR. Paper presented at: PCR London Valves. London: United Kingdom; 2019. https:\/\/doi.org\/10.4244\/EIJV15I7A103."},{"key":"1466_CR30","doi-asserted-by":"publisher","unstructured":"Maisano F. CardiovalveDevice Attributes, Implant Procedure and Early Results. Paper presented at: Transcatheter cardiovascular therapeutics (TCT). San Diego, CA: 2018, DOI: https:\/\/doi.org\/10.4244\/EIJ-D-18-00343.","DOI":"10.4244\/EIJ-D-18-00343"},{"issue":"3","key":"1466_CR31","doi-asserted-by":"publisher","first-page":"e008425","DOI":"10.1161\/CIRCINTERVENTIONS.119.008425","volume":"13","author":"M Guerrero","year":"2020","unstructured":"Guerrero M, Vemulapalli S, Xiang Q, et al. Thirty-day outcomes of transcatheter mitral valve replacement for degenerated mitral bioprotheses (valve-in-valve), failed surgical rings (valve-in-ring), and native valve with severe mitral annular calcification (valve-in-mitral annular calcification) in the United States: data from the Society of Thoracic Surgeons\/American College of Cardiology\/Transcatheter Valve Therapy Registry. Circ Cardiovasc Interv. 2020;13(3):e008425.","journal-title":"Circ Cardiovasc Interv."},{"issue":"5","key":"1466_CR32","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/eurheartj\/ehy590","volume":"40","author":"SH Yoon","year":"2019","unstructured":"Yoon SH, Whisenant BK, Bleiziffer S, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40(5):441\u201351. https:\/\/doi.org\/10.1093\/eurheartj\/ehy590.","journal-title":"Eur Heart J."},{"key":"1466_CR33","doi-asserted-by":"crossref","unstructured":"\u2022 Sorajja P, G\u00f6ssl M, Babaliaros V, et al. Novel Transcatheter Mitral Valve Prosthesis for Patients With Severe Mitral Annular Calcification. J Am Coll Cardiol. 2019;74(11):1431\u201340. Transcatheter mitral valve replacement in severe mitral annular calcification with a dedicated prosthesis is feasible and can result in MR relief with symptom improvement.","DOI":"10.1016\/B978-0-323-54695-9.00040-8"},{"issue":"11","key":"1466_CR34","doi-asserted-by":"publisher","first-page":"e983","DOI":"10.4244\/EIJ-D-19-00444","volume":"15","author":"A Coisne","year":"2019","unstructured":"\u2022 Coisne A, Pontana F, Tch\u00e9tch\u00e9 D, et al. Transcatheter mitral valve replacement: factors associated with screening success and failure. EuroIntervention. 2019;15(11):e983\u20139. Anatomical issues remain the most important factor limiting the feasibility of TMVI. https:\/\/doi.org\/10.4244\/EIJ-D-19-00444.","journal-title":"EuroIntervention"},{"issue":"19","key":"1466_CR35","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.jacc.2015.08.881","volume":"66","author":"HB Ribeiro","year":"2015","unstructured":"Ribeiro HB, Nombela-Franco L, Mu\u00f1oz-Garc\u00eda AJ, et al. Predictors and impact of myocardial injury after transcatheter aortic valve replacement: a multicenter registry. J Am Coll Cardiol. 2015;66(19):2075\u201388.","journal-title":"J Am Coll Cardiol."},{"key":"1466_CR36","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/S0140-6736(16)00558-4","volume":"387","author":"RA Nishimura","year":"2016","unstructured":"Nishimura RA, Vahanian A, Eleid MF, Mack MJ. Mitral valve disease\u2013current management and future challenges. Lancet. 2016;387:1324\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(16)00558-4.","journal-title":"Lancet"},{"issue":"24","key":"1466_CR37","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med. 2018;379(24):2307\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1806640.","journal-title":"N Engl J Med."},{"key":"1466_CR38","doi-asserted-by":"publisher","unstructured":"Lim D. Contemporary Outcomes with MitraClipTM (NTR\/XTR) System in Primary Mitral Regurgitation: Results from the Global EXPAND Study. Paper presented at ACC.20\/WCC virtual 2020, DOI: https:\/\/doi.org\/10.4250\/jcvi.2020.0154.","DOI":"10.4250\/jcvi.2020.0154"}],"updated-by":[{"DOI":"10.1007\/s11886-021-01502-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000}}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01466-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-021-01466-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01466-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T21:06:04Z","timestamp":1627679164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-021-01466-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1466"],"URL":"https:\/\/doi.org\/10.1007\/s11886-021-01466-7","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]},"assertion":[{"value":"18 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2021","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11886-021-01502-6","URL":"https:\/\/doi.org\/10.1007\/s11886-021-01502-6","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"Thomas Modine is a consultant for Boston Scientific, Medtronic, Edwards, Microport, GE, and Abbott; and he received a research support grant from Edwards. Darren Mylotte is a consultant for Medtronic, Boston Scientific, and Microport. Dr. Ralph Stephan von Bardeleben is a consultant for Abbott, Boston Scientific, Cardiac Dimensions, Edwards Lifesciences, and Medtronic. Walid Ben Ali, Reda Ibrahim, and Josep Rhod\u00e8s declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"37"}}